In a formal statement, the President of the World Anti-Doping Agency (WADA) voiced concerns about ongoing issues within Spain’s anti-doping framework and noted that positive cases had not always been addressed promptly despite being under regular monitoring. This acknowledgement underscores the seriousness with which WADA treats the integrity of sport and the need for timely corrective action.
WADA communications also addressed media reports alleging irregularities within the Spanish Agency for the Protection of the Doping System, known as CELAD. The organization urged observers to consider the latest information emerging from these allegations and emphasized its ongoing supervisory role in the compliance process.
The agency stressed that it does not overlook any case and continues to pursue outcomes through a robust consequences management system. While some cases remain unresolved, WADA confirmed that its process is comprehensive and persistent, with attention to due process and fair resolution across all levels of enforcement.
Significantly, WADA disclosed that in 2023 it withdrew three Biological Passport (ABP) cases from CELAD and directed them to the appropriate international federations for handling. In other ABP matters, WADA imposed explicit deadlines on CELAD to issue determinations. These actions illustrate a proactive stance aimed at ensuring timely adjudication and alignment with global standards.
WADA noted that it has recently become aware of ongoing compliance concerns related to CELAD as part of its monitoring program. The agency described a range of topics associated with surveillance, controls, and results management. In response, WADA delivered to CELAD a formal report outlining corrective actions that must be addressed promptly, including several overdue cases. The situation remains active and under close watch.
Additional concerns center on the implementation of Spain’s 2021 Anti-Doping Code. While WADA supported the enactment of the code, it became evident that the practical interpretation and application did not consistently meet the requirements of the World Anti-Doping Code. WADA reserves the right to request legislative changes if laws or their application diverge from the Code, and it identified a royal decree from October 2017 that raised potential non-compliance issues without prior consultation. This development could introduce further compliance challenges for CELAD in the near term.
In response to these developments, the anti-doping community, including medical and sports bodies, remains highly attentive. WADA conveyed that it is very aware of the situation and stressed that constructive cooperation from CELAD and related bodies is essential for sustained improvement. It is unacceptable when positive cases are not addressed in a timely manner, particularly when monitoring mechanisms are in place to safeguard athletes and the sport’s reputation.
Looking ahead, WADA indicated it will continue to engage CELAD and all national and international anti-doping organizations to ensure adherence to the highest standards consistent with the World Anti-Doping Code. The organization reaffirmed its commitment to pursuing cases when warranted and to supporting the broader objective of clean sport through a rigorous enforcement framework.
Experts note that the issues under review have potential implications for the broader Spanish sporting landscape. WADA emphasized that a thorough, transparent investigation is underway, with the aim of implementing effective remedies and strengthening governance. In the months ahead, the outcomes of these inquiries are expected to guide reforms, improve compliance, and restore confidence among athletes, teams, and fans alike. The ongoing process reflects WADA’s enduring dedication to protecting sport’s integrity on a global scale.